Control of endothelial cell function and arteriogenesis by MEG3:EZH2 epigenetic regulation of integrin expression.

ChIRP EZH2 MEG3 MT: RNA and epigenetic editing Special Issue PRC2 RNA binding arteriogenesis endothelial cells limb ischemia lncRNA polycomb

Journal

Molecular therapy. Nucleic acids
ISSN: 2162-2531
Titre abrégé: Mol Ther Nucleic Acids
Pays: United States
ID NLM: 101581621

Informations de publication

Date de publication:
11 Jun 2024
Historique:
received: 15 11 2022
accepted: 14 03 2024
medline: 15 4 2024
pubmed: 15 4 2024
entrez: 15 4 2024
Statut: epublish

Résumé

Epigenetic processes involving long non-coding RNAs regulate endothelial gene expression. However, the underlying regulatory mechanisms causing endothelial dysfunction remain to be elucidated. Enhancer of zeste homolog 2 (EZH2) is an important rheostat of histone H3K27 trimethylation (H3K27me3) that represses endothelial targets, but EZH2 RNA binding capacity and EZH2:RNA functional interactions have not been explored in post-ischemic angiogenesis. We used formaldehyde/UV-assisted crosslinking ligation and sequencing of hybrids and identified a new role for maternally expressed gene 3 (MEG3). MEG3 formed the predominant RNA:RNA hybrid structures in endothelial cells. Moreover, MEG3:EZH2 assists recruitment onto chromatin. By EZH2-chromatin immunoprecipitation, following MEG3 depletion, we demonstrated that MEG3 controls recruitment of EZH2/H3K27me3 onto integrin subunit alpha4 (

Identifiants

pubmed: 38617973
doi: 10.1016/j.omtn.2024.102173
pii: S2162-2531(24)00060-X
pmc: PMC11015509
doi:

Types de publication

Journal Article

Langues

eng

Pagination

102173

Informations de copyright

© 2024.

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Auteurs

Hywel Dunn-Davies (H)

Wellcome Centre for Cell Biology, University of Edinburgh, Michael Swann Building Max Born Crescent, King's Buildings, Edinburgh EH9 3BF, UK.

Tatiana Dudnakova (T)

University/British Heart Foundation Centre for Cardiovascular Science, Queen's Medical Research Institute (QMRI), The University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.

Antonella Nogara (A)

University/British Heart Foundation Centre for Cardiovascular Science, Queen's Medical Research Institute (QMRI), The University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.

Julie Rodor (J)

University/British Heart Foundation Centre for Cardiovascular Science, Queen's Medical Research Institute (QMRI), The University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.

Anita C Thomas (AC)

Bristol Medical School, Translational Health Sciences, University of Bristol, Research and Teaching Floor Level 7, Queens Building, Bristol Royal Infirmary, Bristol BS2 8HW, UK.

Elisa Parish (E)

University/British Heart Foundation Centre for Cardiovascular Science, Queen's Medical Research Institute (QMRI), The University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.

Philippe Gautier (P)

MRC Human Genetics Unit, MRC Institute of Genetics and Cancer, The University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK.

Alison Meynert (A)

MRC Human Genetics Unit, MRC Institute of Genetics and Cancer, The University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK.

Igor Ulitsky (I)

Department of Immunology and Regenerative Biology and Department of Molecular Neuroscience, Weizmann-UK Building rm. 007, Weizmann Institute of Science Rehovot 76100, Israel.

Paolo Madeddu (P)

Bristol Medical School, Translational Health Sciences, University of Bristol, Research and Teaching Floor Level 7, Queens Building, Bristol Royal Infirmary, Bristol BS2 8HW, UK.

Andrea Caporali (A)

University/British Heart Foundation Centre for Cardiovascular Science, Queen's Medical Research Institute (QMRI), The University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.

Andrew Baker (A)

University/British Heart Foundation Centre for Cardiovascular Science, Queen's Medical Research Institute (QMRI), The University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.

David Tollervey (D)

Wellcome Centre for Cell Biology, University of Edinburgh, Michael Swann Building Max Born Crescent, King's Buildings, Edinburgh EH9 3BF, UK.

Tijana Mitić (T)

University/British Heart Foundation Centre for Cardiovascular Science, Queen's Medical Research Institute (QMRI), The University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.

Classifications MeSH